A Q4 2020 Earnings — Agilent Technologies, Inc. Revenue & Financial Results | Market Cap Arena

AAgilent Technologies, Inc.

$33B

Q4 2020 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1.5B+8.5% YoY

Gross Profit

$788M53.1% margin

Operating Income

$299M20.2% margin

Net Income

$222M15.0% margin

EPS (Diluted)

$0.71

QoQ Revenue Growth

+17.6%

Cash Flow

Operating Cash Flow

$377M

Free Cash Flow

$350M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$9.6B

Total Liabilities

$4.8B

Stockholders' Equity

$4.9B

Cash & Equivalents

$1.4B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.5B	$1.4B	+8.5%
Gross Profit	$788M	$737M	+6.9%
Operating Income	$299M	$250M	+19.6%
Net Income	$222M	$194M	+14.4%

Revenue Segments

Life Sciences and Applied Markets

$671M45%

Agilent CrossLab

$518M35%

Diagnostics and Genomics

$294M20%

Geographic Segments

Americas

$566M38%

Asia Pacific

$522M35%

Europe

$395M27%